Dedicated Molecular Imaging Corporation is a San Diego-based medical technology company specializing in the development and commercialization of mission-specific imaging equipment.
What is molecular imaging? ‘Molecular imaging’ refers to imaging molecular pathways for characterizing biological functions. One such function is glucose utilization, which can be used to depict the presence (or absence) of cancerous tumors by their signature elevated metabolic rate. Molecular imaging with FDG-PET* has become a clinical mainstay for detecting many types cancer based on it’s ability to represent glucose metabolism.
*positron emission tomography is a 3D imaging technology, FDG (flurodeoxyglucose) is a radio-labeled sugar analog molecule
Our primary focus is on the detection of primary breast cancer using our breast-specific molecular imaging technology. We aim to improve on perplexing problems facing breast care such as:
Conventional PET scanners, that are designed to image the whole body, are unable to detect small, emergent tumors within the breast. By directing all imaging resources exclusively to the breast anatomy, the Company’s ‘breast- dedicated’ PET scanner is directed at providing the image fidelity needed to fully depict important breast tumors while they are still very small and easy to treat.